Elevated Peripheral Benzodiazepine Receptor Expression in Simian Immunodeficiency Virus Encephalitis

References

• Aloisi F (2001). Immune function of microglia. Glia 36: 165–179.
   PubMed Web of Science ®Google Scholar
• Banati RB, Goerres GW, Myers R, Gunn RN, Turkheimer FE, Kreutzberg GW, Brooks DJ, Jones T, Duncan JS (1999). (11C1(R)-PK11195 positron emission to-mography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 53: 2199–2203.
   PubMedGoogle Scholar
• Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000). The periph-eral benzodiazepine binding site in the brain in multi-ple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123\(Pt 11): 2321–2337.
   Google Scholar
• Berman NE, Marcario JK, Yong C, Raghavan R, Raymond LA, Joag SV, Narayan O, Cheney PD (1999). Microglial activation and neurological symptoms in the SW model of neuroAIDS: association of MHC-II and MMP-9 ex-pression with behavioral deficits and evoked potential changes. Neurobiol Dis 6: 486–498.
   Google Scholar
• Bono F, Lamarche I, Prabonnaud V, Le Fur G, Herbert JM (1999). Peripheral benzodiazepine receptor agonists ex-hibit potent antiapoptotic activities. Biochem Biophys Res Commun 265: 457–461.
   PubMed Web of Science ®Google Scholar
• Brown RC, Papadopoulos V (2001). Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis. Int Rev Neurobiol 46: 117–143.
   Google Scholar
• Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001). In-vivo mea-surement of activated microglia in dementia. Lancet 358: 461–467.
   PubMed Web of Science ®Google Scholar
• Gavish M, Weizman R (1997). Role of peripheral-type benzodiazepine receptors in steroidogenesis. Clin Neu-ropharmacol 20: 473–481.
   Google Scholar
• Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Im-munocytochemical quantitation of human immunode-ficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762.
   PubMed Web of Science ®Google Scholar
• Guilarte TR, Kuhlmann AC, O'Callaghan JP, Miceli RC (1995). Enhanced expression of peripheral benzodi-azepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. Neurotoxicology 16: 441–450.
   Google Scholar
• Johnston C, Jiang W, Chu T, Levine B (2001). Identi-fication of genes involved in the host response to neurovirulent alphavirus infection. J Virol 75: 10431–10445.
   Google Scholar
• Kuhlmann AC, Guilarte TR (1997). The peripheral benz o di-azepine receptor is a sensitive indicator of domoic acid neurotoxicity. Brain Res 751: 281–288.
   Google Scholar
• Kuhlmann AC, Guilarte TR (1999). Regional and tem-poral expression of the peripheral benzodiazepine re-ceptor in MPTP neurotoxicity. Toxicol Sci 48: 107–116.
   PubMed Web of Science ®Google Scholar
• Kuhlmann AC, Guilarte TR (2000). Cellular and subcellu-lar localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 74: 1694–1704.
   PubMed Web of Science ®Google Scholar
• Lane JH, Sasseville VG, Smith MO, Vogel P, Pauley DR, Heyes MP, Lackner AA (1996). Neuroinvasion by simian immunodeficiency virus coincides with increased num-bers of perivascular macrophages/microglia and in-trathecal immune activation. J NeuroVirol 2: 423–432.
   PubMed Web of Science ®Google Scholar
• Lokensgard JR, Hu S, Hegg CC, Thayer SA, Gekker G, Peterson PK (2001). Diazepam inhibits HIV-1 Tat-induced migration of human microglia. J NeuroVirol 7: 481–486.
   Google Scholar
• Papadopoulos V, Amri H, Li H, Yao Z, Brown RC, Vidic B, Culty M (2001). Structure, function and regulation of the mitochondrial peripheral-type benzodiazepine receptor. Therapie 56: 549–556.
   Google Scholar
• Seilhean D, Kobayashi K, He Y, Uchihara T, Rosenblum O, Katlama C, Bricaire F, Duyckaerts C, Hauw JJ (1997). Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol (Berl) 93: 508–517.
   PubMed Web of Science ®Google Scholar
• Sopper S, Demuth M, Stahl-Hennig C, Hunsmann G, Plesker R, Coulibaly C, Czub S, Ceska M, Koutsilieri E, Riederer P, Brinkmann R, Katz M, ter Meulen V (1996). The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of iso-lated microglia and peripheral macrophages from rhesus monkey. Virology 220: 320–329.
   Google Scholar
• Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, Antel JP (1997). PK11195 binding to the pe-ripheral benzodiazepine receptor as a marker of mi-croglia activation in multiple sclerosis and experimen-tal autoimmune encephalomyelitis. J Neurosci Res 50: 345–353.
   PubMed Web of Science ®Google Scholar
• Walsh DT, Perry VH, Minghetti L (2000). Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease. Glia 29: 392–396.
   Google Scholar
• Weihe E, Nohr D, Sharer L, Murray E, Rausch D, Eiden L (1993). Cortical astrocytosis in juvenile rhesus monkeys infected with simian immunodeficiency virus. Neuro-report 4: 263–266.
   Google Scholar
• Weis S, Haug H, Budka H (1993). Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol Appl Neurobiol 19: 329–335.
   Google Scholar
• Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001). Increased macrophage chemoattractant protein-1 in cerebrospinal fluid pre-cedes and predicts simian immunodeficiency virus en-cephalitis. /Infect Dis 184: 1015–1021.
   PubMed Web of Science ®Google Scholar
• Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M Jr, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE (1999). High viral load in the cerebrospinal fluid and brain correlates with severity of simian im-munodeficiency virus encephalitis. J Virol 73: 10480–10488.
   PubMed Web of Science ®Google Scholar